201 related articles for article (PubMed ID: 18811040)
1. The role of bone morphogenetic protein-7 (Osteogenic Protein-1) in the treatment of tibial fracture non-unions. An overview of the use in Belgium.
Desmyter S; Goubau Y; Benahmed N; de Wever A; Verdonk R
Acta Orthop Belg; 2008 Aug; 74(4):534-7. PubMed ID: 18811040
[TBL] [Abstract][Full Text] [Related]
2. External fixation of tibial pilon fractures and fracture healing.
Ristiniemi J
Acta Orthop Suppl; 2007 Jun; 78(326):3, 5-34. PubMed ID: 17465283
[TBL] [Abstract][Full Text] [Related]
3. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
Calori GM; Tagliabue L; Gala L; d'Imporzano M; Peretti G; Albisetti W
Injury; 2008 Dec; 39(12):1391-402. PubMed ID: 19027898
[TBL] [Abstract][Full Text] [Related]
4. Healing of fresh tibial fractures with OP-1. A preliminary report.
Maniscalco P; Gambera D; Bertone C; Rivera F; Crainz E; Urgelli S
Acta Biomed; 2002; 73(1-2):27-33. PubMed ID: 12233274
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human bone morphogenetic protein 2 enhances bone healing in an experimental model of fractures at risk of non-union.
Eckardt H; Christensen KS; Lind M; Hansen ES; Hall DW; Hvid I
Injury; 2005 Apr; 36(4):489-94. PubMed ID: 15755429
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenic protein and its application in trauma cases: a current concept update.
Vaibhav B; Nilesh P; Vikram S; Anshul C
Injury; 2007 Nov; 38(11):1227-35. PubMed ID: 17307180
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of BMP-7: the UK perspective.
Giannoudis PV; Tzioupis C
Injury; 2005 Nov; 36 Suppl 3():S47-50. PubMed ID: 16188550
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery.
Nordsletten L
Curr Med Res Opin; 2006; 22 Suppl 1():S13-7; S23. PubMed ID: 16882365
[TBL] [Abstract][Full Text] [Related]
9. Fibula and tibia fusion with cancellous allograft vitalised with autologous bone marrow: first results for infected tibial non-union.
Ateschrang A; Ochs BG; Lüdemann M; Weise K; Albrecht D
Arch Orthop Trauma Surg; 2009 Jan; 129(1):97-104. PubMed ID: 18677497
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human bone morphogenetic proteins in the treatment of fractures.
Kain MS; Einhorn TA
Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins in clinical applications.
Gautschi OP; Frey SP; Zellweger R
ANZ J Surg; 2007 Aug; 77(8):626-31. PubMed ID: 17635273
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?
Szpalski M; Gunzburg R
Acta Orthop Belg; 2005 Apr; 71(2):133-48. PubMed ID: 16152845
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients.
Ronga M; Baldo F; Zappalà G; Cherubino P;
Injury; 2006 Sep; 37 Suppl 3():S51-6. PubMed ID: 16952362
[TBL] [Abstract][Full Text] [Related]
14. Application of recombinant BMP-7 on persistent upper and lower limb non-unions.
Dimitriou R; Dahabreh Z; Katsoulis E; Matthews SJ; Branfoot T; Giannoudis PV
Injury; 2005 Nov; 36 Suppl 4():S51-9. PubMed ID: 16291324
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein (BMP) for fracture healing in adults.
Garrison KR; Shemilt I; Donell S; Ryder JJ; Mugford M; Harvey I; Song F; Alt V
Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD006950. PubMed ID: 20556771
[TBL] [Abstract][Full Text] [Related]
16. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7.
Dahabreh Z; Dimitriou R; Giannoudis PV
Injury; 2007 Mar; 38(3):371-7. PubMed ID: 17070526
[TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites.
Cook SD
Orthopedics; 1999 Jul; 22(7):669-71. PubMed ID: 10418861
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins in open fractures: past, present, and future.
Nauth A; Ristiniemi J; McKee MD; Schemitsch EH
Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions.
Bong MR; Capla EL; Egol KA; Sorkin AT; Distefano M; Buckle R; Chandler RW; Koval KJ
Bull Hosp Jt Dis; 2005; 63(1-2):20-3. PubMed ID: 16536213
[TBL] [Abstract][Full Text] [Related]
20. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model.
Alt V; Heissel A
Curr Med Res Opin; 2006; 22 Suppl 1():S19-22. PubMed ID: 16882366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
